aminolevulinic acid has been researched along with Liver Failure in 2 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Liver Failure: Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Results of NTBC therapy used in three infants with type I tyrosinemia who presented with acute liver failure are reported." | 3.70 | [Favorable outcome of treatment with NTBC of acute liver insufficiency disclosing hereditary tyrosinemia type I]. ( Barkaoui, E; Bernard, O; Debray, D; Habès, D; Ogier, H, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruneau, N | 1 |
St-Vil, D | 1 |
Luks, FI | 1 |
LaBerge, JM | 1 |
Bensoussan, AL | 1 |
Blanchard, H | 1 |
Barkaoui, E | 1 |
Debray, D | 1 |
Habès, D | 1 |
Ogier, H | 1 |
Bernard, O | 1 |
2 other studies available for aminolevulinic acid and Liver Failure
Article | Year |
---|---|
[Surgical and metabolic aspects of liver transplantation for tyrosinemia].
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Aminolevulinic Acid; Central Nervous System Diseas | 1993 |
[Favorable outcome of treatment with NTBC of acute liver insufficiency disclosing hereditary tyrosinemia type I].
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Acute Disease; Amino Acid Metabolism, Inborn Errors; Aminolevul | 1999 |